Mercado de rastreio de saúde Ásia-Pacífico, por tipo de teste (testes de colesterol, teste de diabetes , rastreio de cancro, teste de check-up geral, DST, teste de pressão arterial e outros), tipo de pacote (exame de saúde básico, perfil de idoso, exame de saúde feminino, homens Exame de saúde, exame cardíaco , exame de diabetes e outros), tipo de painel (painéis multiteste e painéis de teste único), tipo de amostra (sangue, urina, soro , saliva e outros), tecnologia (imunoensaios, imagens médicas, QPCR (quantitativo Reação em cadeia da polimerase), Q-FISH (fluorescência quantitativa, hibridização in situ), TRF (fragmento de restrição terminal), STELA (análise de comprimento de telómero único) e outros), condição (doença cardiovascular, distúrbios metabólicos, cancro, condições inflamatórias, distúrbios músculo-esqueléticos , Condições Neurológicas, Complicações da Hepatite C, Condições Relacionadas com a Imunologia e Outras), Locais de Colheita de Amostras (Hospital, Residências, Laboratórios de Diagnóstico, Escritórios e Outros), Canal de Distribuição (Licitações Diretas, Vendas a Retalho e Outros), País (Japão, China , Coreia do Sul, Índia, Austrália, Singapura, Tailândia, Malásia, Indonésia, Filipinas, Vietname, Resto da Ásia-Pacífico ) Tendências e previsões da indústria para 2028.
Análise de Mercado e Insights: Mercado de Rastreio de Saúde Ásia-Pacífico
Espera-se que o mercado de exames de saúde da Ásia-Pacífico ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 13,6% no período de previsão de 2021 a 2028 e deverá atingir os 109.704,00 milhões de dólares até 2028. O aumento do número de doenças crónicas, a população geriátrica e a crescente consciencialização sobre a deteção precoce e o tratamento de doenças são os principais impulsionadores que impulsionaram a procura do mercado no período de previsão.
O rastreio de saúde é um método importante de detecção precoce de uma doença específica. Os testes de rastreio são frequentemente utilizados na medicina preventiva para identificar se um indivíduo apresenta sinais precoces dos fatores de risco de uma doença. A doença, que pode ser detetada por rastreio, inclui cancro, diabetes, colesterol elevado, hipertensão arterial e osteoporose.
A crescente consciencialização entre as pessoas sobre a detecção precoce e o tratamento de doenças e o aumento das despesas de saúde estão a aumentar a procura de rastreios de saúde.
A crescente procura de exames de saúde devido à sua eficácia, juntamente com o crescente número de prestadores de serviços, e o aumento da campanha de sensibilização por parte dos intervenientes privados e públicos sobre os exames de saúde estão a impulsionar o crescimento do mercado de exames de saúde no período de previsão. No entanto, o elevado custo do teste de rastreio pode dificultar o crescimento do mercado no período de previsão.
O relatório de mercado de exames de saúde da Ásia-Pacífico fornece detalhes de quota de mercado, novos desenvolvimentos e análise de pipeline de produtos, o impacto dos participantes do mercado doméstico e localizado, analisa as oportunidades em termos de bolsas de receitas emergentes, mudanças nas regulamentações de mercado, aprovações de produtos, decisões estratégicas , lançamentos de produtos, expansões geográficas e inovações tecnológicas no mercado. Para compreender a análise e o cenário do mercado, contacte-nos para obter um Analyst Brief; a nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir a meta desejada.
Âmbito e dimensão do mercado de rastreio de saúde da Ásia-Pacífico
O mercado de exames de saúde da Ásia-Pacífico está segmentado em oito segmentos notáveis com base no tipo de teste, tipo de embalagem, tipo de painel, tipo de amostra, tecnologia, condição, locais de recolha de amostras e canal de distribuição . O crescimento entre segmentos ajuda-o a analisar os nichos de crescimento e as estratégias para abordar o mercado e determinar as suas principais áreas de aplicação e a diferença nos seus mercados-alvo.
- Com base no tipo de teste, o mercado de exames de saúde da Ásia-Pacífico está segmentado em testes de colesterol, testes de diabetes, exames de cancro, testes de check-up geral, DST, testes de pressão arterial, entre outros. Em 2021, prevê-se que o segmento dos testes de colesterol domine o mercado devido ao aumento da população geriátrica e ao estilo de vida sedentário.
- Com base no tipo de pacote, o mercado de exames de saúde da Ásia-Pacífico está segmentado em exames básicos de saúde, perfil de idoso, exame de saúde feminino, exame de saúde masculino, exame cardíaco, exame de diabetes, entre outros. Em 2021, prevê-se que o segmento básico dos exames de saúde domine o mercado devido ao aumento dos gastos com a saúde nos países asiáticos.
- Com base no tipo de painel, o mercado de exames de saúde da Ásia-Pacífico está segmentado em painéis multi-testes e painéis de testes únicos. Em 2021, prevê-se que o segmento dos painéis multi-teste domine o mercado devido ao avanço tecnológico dos laboratórios desta região
- Com base no tipo de amostra, o mercado de exames de saúde da Ásia-Pacífico está segmentado em sangue, urina, soro, saliva, entre outros. Em 2021, espera-se que o segmento do sangue domine o mercado porque é o maior tipo de amostra e pode ser diagnosticado em quase todos os laboratórios.
- Com base na tecnologia, o mercado de exames de saúde da Ásia-Pacífico está segmentado em imunoensaios, imagens médicas, QPCR (Reação em Cadeia da Polimerase Quantitativa), Q-FISH (Fluorescência Quantitativa, hibridização in situ), TRF (Fragmento de Restrição Terminal), STELA ( Análise de comprimento de telómero único) e outros. Em 2021, prevê-se que o segmento dos imunoensaios domine o mercado porque o mercado asiático é um dos mercados emergentes de cuidados de saúde com o crescente turismo médico, o que deverá aumentar a procura de todas as técnicas de rastreio por esta razão.
- On the basis of condition, the Asia-Pacific health screening market is segmented into cardiovascular disease, metabolic disorders, cancer, inflammatory conditions, musculoskeletal disorders, neurological conditions, Hepatitis-C complications, immunology-related conditions, and others. In 2021, cardiovascular disease segment is expected to dominate the market because of high prevalence of cardiovascular diseases in this region also
- On the basis of sample collection sites, the Asia-Pacific health screening market is segmented into hospitals, homes, diagnostic laboratories, offices, and others. In 2021, hospitals segment is expected to dominate the market as the infrastructure is growing in Asia-pacific region with increasing hospitals numbers
- On the basis of distribution channel, the Asia-Pacific health screening market is segmented into direct tenders, retail sales, and others. In 2021, direct tender segment is expected to dominate the market because of increase in overall sales of health screening programs.
Asia-Pacific Health Screening Market Country Level Analysis
Asia-Pacific health screening market is analyzed, and market size information is provided on the test type, package type, panel type, sample type, technology, condition, sample collection sites, and distribution channel.
The countries covered in the Asia-Pacific health screening market report are Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific. India in the Asia-Pacific region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of innovative R&D and new product launches and approvals.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Rise in Geriatric Population and Increased Incidence of Cancer and CVD Diseases are Boosting the Market Growth of Asia-Pacific Health Screening Products
Asia-Pacific health screening market also provides you with detailed market analysis for every country's growth in the health screening product industry with drugs sales, the impact of advancement, technology, and changes in regulatory scenarios with their support for the Health Screening market. The data is available for the historic period 2010 to 2019.
Competitive Landscape and Asia-Pacific Health Screening Market Share Analysis
O panorama competitivo do mercado de exames de saúde da Ásia-Pacífico fornece detalhes dos concorrentes. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos, pipelines de testes de produtos, aprovações de produtos, patentes, largura do produto, e respiração, domínio da aplicação, curva da linha de vida da tecnologia. Os dados fornecidos acima estão apenas relacionados com o foco da empresa relacionado com o mercado de exames de saúde da Ásia-Pacífico.
As principais empresas que operam no mercado de exames de saúde da Ásia-Pacífico são a Sonic Healthcare Limited, Quest Diagnostics Incorporated, Healius Limited, Quidel Corporation, Eurofins Scientific, GRAIL, , Exact Sciences Corporation, SYNLAB International GmbH, UNILABS, LabPLUS, BioReference Laboratories , , ACM Global Laboratories, Cerba Healthcare, , Innova Medical Group, AMEDES Holding GmbH, RadNet, Inc., Natera, Inc., Trinity Biotech, Nuffield Health, RepeatDx, NeoGenomics Laboratories, HU Group Holdings, Inc., Lifelabs, ARUP Laboratories , Q2 Solutions, Genova Diagnostics, Life Length, DNA Labs India, , Telomere Diagnostics, Charles River Laboratories, Ambry Genetics, SpectraCell Laboratories, Inc., Dr.
Muitos lançamentos e acordos de produtos são também iniciados pelas empresas de todo o mundo, o que também acelera o mercado de exames de saúde da Ásia-Pacífico.
Por exemplo,
- Em março de 2020, a Sonic Healthcare anunciou que adquiriu o Pathologie Hamburg - um laboratório de prática patológica. Esta aquisição proporcionou à empresa maiores capacidades de produção e de testes. Isto impulsionará o mercado para a empresa no período de previsão.
A colaboração, o lançamento de produtos, a expansão do negócio, a atribuição de prémios e reconhecimento, as joint ventures e outras estratégias do player de mercado estão a potenciar o mercado da empresa no mercado de Triagem de Saúde, que também oferece o benefício para a organização melhorar a sua oferta de Triagem de Saúde.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC HEALTH SCREENING MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TEST TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 DISTRIBUTION CHANNELUSER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 REGULATIONS
5.1 WORLD HEALTH ORGANIZATION
5.2 NORTH AMERICA
5.3 EUROPE
6 INDUSTRIAL INSIGHTS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISING PREVALENCE OF CHRONIC DISEASES
7.1.2 GROWING GERIATRIC POPULATION
7.1.3 GOVERNMENT INITIATIVES UNDERTAKEN TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES
7.1.4 RISING PER CAPITA INCOME AND HEALTHCARE EXPENDITURE
7.1.5 GRWOING NUMBER OF SCREENING PROGRAMS WORLDWIDE
7.2 RESTRAINTS
7.2.1 SCRACITY OF TECHNICALLY-SKILLED PROFESSIONALS
7.2.2 RISKS ASSOCIATED WITH SCREENING
7.2.3 LACK OF ACCESSIBILITY
7.3 OPPORTUNITIES
7.3.1 TECHNOLOGICAL ADVANCEMENTS IN HEALTH SCREENING
7.3.2 ACQUSITIONS AND MERGERS AMONG THE MARKET
7.3.3 NEW PRODUCT LAUNCHES IN THE MARKET
7.4 CHALLENGES
7.4.1 HIGHER COST OF HEALTH SCREENING
7.4.2 OPERATIONAL BARRIERS FACED IN CONDUCTING SCREENING TESTS
8 COVID-19 IMPACT ON ASIA PACIFIC HEALTH SCREENING MARKET
8.1 PRICE IMPACT
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC DECISIONS FOR MANUFACTURERS
8.5 CONCLUSION
9 ASIA PACIFIC HEALTH SCREENING MARKET, BY TEST TYPE
9.1 OVERVIEW
9.2 CHOLESTEROL TESTS
9.2.1 TOTAL CHOLESTEROL TESTS
9.2.2 TRIGLYCERIDES
9.2.3 LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL
9.2.4 HIGH-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL
9.3 DIABETES TEST
9.3.1 FASTING/RANDOM BLOOD SUGAR TEST
9.3.2 A1C TEST
9.3.3 GLUCOSE TOLERANCE TEST
9.4 CANCER SCREENING
9.4.1 LIQUID BIOPSY
9.4.2 MAMMOGRAMS, OSTEOPOROSIS, BREAST MRI AND PAP SMEAR TESTS
9.4.3 LOW-DOSE HELICAL COMPUTED TOMOGRAPHY
9.4.4 COLORECTAL CANCER SCREENING TEST (STOOL TESTS, SIGMOIDOSCOPY, COLONOSCOPY, BLOOD-BASED DNA TEST, DOUBLE-CONTRAST BARIUM ENEMA (DCBE), AND SINGLE-SPECIMEN GFOBT)
9.4.5 PROSTATE SPECIFIC ANTIGEN (PSA) TEST
9.4.6 NEW-EARLY DETECTION CANCER TESTS
9.4.7 ALPHA FETOPROTEIN BLOOD TEST
9.4.8 CA-125 TEST
9.4.9 OTHERS
9.5 GENERAL CHECK UP TEST
9.5.1 REGULAR CHECK UP
9.5.1.1 REGULAR BLOOD TEST
9.5.1.2 X-RAYS
9.5.1.3 ECG
9.5.1.4 FECALYSIS
9.5.1.5 URINALYSIS
9.5.1.6 BMI
9.5.1.7 OTHERS
9.5.2 EYE CHECK UP
9.5.3 DENTAL TEST
9.5.4 HEARING TEST
9.6 STD’S
9.6.1 CHLAMYDIA
9.6.2 GONORRHEA
9.6.3 HPV
9.6.4 HIV
9.6.5 OTHERS
9.7 BLOOD PRESSURE TEST
9.8 OTHERS
9.8.1 LIVER FUNCTION TESTS
9.8.2 KIDNEY PROFILE
9.8.3 OTHERS
10 ASIA PACIFIC HEALTH SCREENING MARKET, BY PANEL TYPE
10.1 OVERVIEW
10.2 MULTI-TEST PANELS
10.3 SINGLE-TEST PANELS
10.3.1 INFLAMMATION TESTS
10.3.2 OXIDATIVE STRESS TESTS
10.3.3 HEAVY METAL TESTS
10.3.4 TELOMERE
11 ASIA PACIFIC HEALTH SCREENING MARKET, BY PACKAGE TYPE
11.1 OVERVIEW
11.2 BASIC HEALTH SCREENING
11.3 SENIOR CITIZEN PROFILE
11.4 WOMEN HEALTH CHECK
11.5 MEN HEALTH CHECK
11.6 HEART CHECK
11.7 DIABETES CHECK
11.8 OTHERS
12 ASIA PACIFIC HEALTH SCREENING MARKET, BY SAMPLE TYPE
12.1 OVERVIEW
12.2 BLOOD
12.3 URINE
12.4 SERUM
12.5 SALIVA
12.6 OTHERS
13 HEALTH SCREENING MARKET, BY TECHNOLOGY
13.1 OVERVIEW
13.2 IMMUNOASSAYS
13.3 MEDICAL IMAGING
13.4 QPCR
13.4.1 MMQPCR (MONOCHROME MULTIPLEX QPCR)
13.4.2 ATLQPCR (ABSOLUTE TELOMERE LENGTH QPCR)
13.5 Q-FISH
13.5.1 PRINS (PRIMED IN SITU SUBTYPE OF Q-FISH)
13.5.2 FLOW-FISH
13.5.3 HT Q-FISH (HIGH THROUGHPUT Q-FISH)
13.6 TRF (TERMINAL RESTRICTION FRAGMENT)
13.7 STELA (SINGLE TELOMERE LENGTH ANALYSIS)
13.8 OTHERS
14 ASIA PACIFIC HEALTH SCREENING MARKET, BY CONDITION
14.1 OVERVIEW
14.2 CARDIOVASCULAR DISEASE
14.2.1 CORONARY HEART DISEASE
14.2.2 ATHEROSCLEROSIS
14.3 METABOLIC DISORDERS
14.3.1 DIABETES MELLITUS
14.3.2 OBESITY
14.4 CANCER
14.5 INFLAMMATORY CONDITIONS
14.5.1 AUTOIMMUNE CONDITIONS
14.5.2 ALLERGIES
14.5.3 ARTHRITIS
14.5.4 ASTHMA
14.5.5 INFLAMMATORY DIGESTIVE PROBLEMS
14.6 MUSCULOSKELETAL DISORDERS
14.6.1 OSTEOPOROSIS
14.6.2 RHEUMATOID ARTHRITIS
14.7 NEUROLOGICAL CONDITIONS
14.7.1 CHRONIC STRESS
14.7.2 ALZHEIMER'S DISEASE
14.8 IMMUNOLOGY-RELATED CONDITIONS
14.9 HEPATITIS C COMPLICATIONS
14.1 OTHERS
15 HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 DIRECT TENDERS
15.3 RETAIL SALES
15.4 OTHERS
16 ASIA PACIFIC HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES
16.1 OVERVIEW
16.2 HOSPITAL
16.2.1 ACUTE CARE HOSPITALS
16.2.2 LONG-TERM CARE HOSPITALS
16.2.3 NURSING FACILITIES
16.2.4 REHABILITATION CENTERS
16.3 HOME
16.4 DIAGNOSTIC LABORATORIES
16.5 OFFICES
16.6 OTHERS
17 ASIA PACIFIC HEALTH SCREENING MARKET, BY REGION
17.1 ASIA-PACIFIC
17.1.1 JAPAN
17.1.2 INDIA
17.1.3 SOUTH KOREA .
17.1.4 AUSTRALIA
17.1.5 SINGAPORE
17.1.6 THAILAND
17.1.7 MALAYSIA
17.1.8 INDONESIA
17.1.9 PHILIPPINES
17.1.10 REST OF ASIA-PACIFIC
18 ASIA PACIFIC HEALTH SCREENING MARKET: COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
19 SWOT ANALYSIS
20 COMPANY PROFILE
20.1 QUEST DIAGNOSTICS INCORPORATED
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 COMPANY SHARE ANALYSIS
20.1.4 PRODUCT PORTFOLIO
20.1.5 RECENT DEVELOPMENTS
20.2 SONIC HEALTHCARE LIMITED
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 COMPANY SHARE ANALYSIS
20.2.4 PRODUCT PORTFOLIO
20.2.5 RECENT DEVELOPMENTS
20.3 LABORATORY CORPORATION OF AMERICA
20.3.1 COMPANY SNAPSHOT
20.3.2 REVENUE ANALYSIS
20.3.3 COMPANY SHARE ANALYSIS
20.3.4 PRODUCT PORTFOLIO
20.3.5 RECENT DEVELOPMENT
20.4 EUROFINS SCIENTIFIC
20.4.1 COMPANY SNAPSHOT
20.4.2 REVENUE ANALYSIS
20.4.3 COMPANY SHARE ANALYSIS
20.4.4 PRODUCT PORTFOLIO
20.4.5 RECENT DEVELOPMENTS
20.5 EXACT SCIENCES CORPORATION
20.5.1 COMPANY SNAPSHOT
20.5.2 REVENUE ANALYSIS
20.5.3 COMPANY SHARE ANALYSIS
20.5.4 PRODUCT PORTFOLIO
20.5.5 RECENT DEVELOPMENTS
20.6 ACM ASIA PACIFIC LABORATORIES
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENT
20.7 AMEDES
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENT
20.8 AMBRY GENETICS
20.8.1 COMPANY SNAPSHOT
20.8.2 SERVICE PORTFOLIO
20.8.3 RECENT DEVELOPMENTS
20.9 ARUP LABORATORIES
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENTS
20.1 BIOREFRENCE LABORATORIES
20.10.1 COMPANY SNAPSHOT
20.10.2 REVENUE ANALYSIS
20.10.3 PRODUCT PORTFOLIO
20.10.4 RECENT DEVELOPMENTS
20.11 CHARLES RIVER
20.11.1 COMPANY SNAPSHOT
20.11.2 REVENUE ANALYSIS
20.11.3 PRODUCT PORTFOLIO
20.11.4 RECENT DEVELOPMENTS
20.12 CERBA HEALTHCARE
20.12.1 COMPANY SNAPSHOT
20.12.2 PRODUCT PORTFOLIO
20.12.3 RECENT DEVELOPMENT
20.13 DNA LABS INDIA
20.13.1 COMPANY SNAPSHOT
20.13.2 SERVICE PORTFOLIO
20.13.3 RECENT DEVELOPMENT
20.14 DR LAL PATH LABS
20.14.1 COMPANY SNAPSHOT
20.14.2 REVENUE ANALYSIS
20.14.3 PRODUCT PORTFOLIO
20.14.4 RECENT DEVELOPMENT
20.15 GENOVA DIGNOSTICS
20.15.1 COMPANY SNAPSHOT
20.15.2 SERVICE PORTFOLIO
20.15.3 RECENT DEVELOPMENT
20.16 GRAIL
20.16.1 COMPANY SNAPSHOT
20.16.2 SERVICE PORTFOLIO
20.16.3 RECENT DEVELOPMENTS
20.17 HEALIUS LIMITED
20.17.1 COMPANY SNAPSHOT
20.17.2 REVENUE ANALYSIS
20.17.3 PRODUCT PORTFOLIO
20.17.4 RECENT DEVELOPMENTS
20.18 H.U. GROUP HOLDINGS, INC.
20.18.1 COMPANY SNAPSHOT
20.18.2 REVENUE ANALYSIS
20.18.3 PRODUCT PORTFOLIO
20.18.4 RECENT DEVELOPMENTS
20.19 INNOVA MEDICAL GROUP
20.19.1 COMPANY SNAPSHOT
20.19.2 PRODUCT PORTFOLIO
20.19.3 RECENT DEVELOPMENT
20.2 LABPLUS
20.20.1 COMPANY SNAPSHOT
20.20.2 PRODUCT PORTFOLIO
20.20.3 RECENT DEVELOPMENT
20.21 LIFELABS
20.21.1 COMPANY SNAPSHOT
20.21.2 SERVICE PORTFOLIO
20.21.3 RECENT DEVELOPMENTS
20.22 LIFE LENGTH
20.22.1 COMPANY SNAPSHOT
20.22.2 SERVICE PORTFOLIO
20.22.3 RECENT DEVELOPMENT
20.23 NATERA, INC.
20.23.1 COMPANY SNAPSHOT
20.23.2 REVENUE ANALYSIS
20.23.3 PRODUCT PORTFOLIO
20.23.4 RECENT DEVELOPMENTS
20.24 NEOGENOMICS LABORATORIES
20.24.1 COMPANY SNAPSHOT
20.24.2 REVENUE ANALYSIS
20.24.3 PRODUCT PORTFOLIO
20.24.4 RECENT DEVELOPMENTS
20.25 NUFFIELD HEALTH
20.25.1 COMPANY SNAPSHOT
20.25.2 PRODUCT PORTFOLIO
20.25.3 RECENT DEVELOPMENT
20.26 Q2 SOLUTIONS
20.26.1 COMPANY SNAPSHOT
20.26.2 SERVICE PORTFOLIO
20.26.3 RECENT DEVELOPMENTS
20.27 QUIDEL CORPORATION
20.27.1 COMPANY SNAPSHOT
20.27.2 REVENUE ANALYSIS
20.27.3 PRODUCT PORTFOLIO
20.27.4 RECENT DEVELOPMENTS
20.28 REPEATDX
20.28.1 COMPANY SNAPSHOT
20.28.2 PRODUCT PORTFOLIO
20.28.3 RECENT DEVELOPMENT
20.29 SONIC HEALTHCARE LIMITED
20.29.1 COMPANY SNAPSHOT
20.29.2 REVENUE ANALYSIS
20.29.3 PRODUCT PORTFOLIO
20.29.4 RECENT DEVELOPMENTS
20.3 SPECTRACELL LABORATORIES, INC.
20.30.1 COMPANY SNAPSHOT
20.30.2 SERVICE PORTFOLIO
20.30.3 RECENT DEVELOPMENT
20.31 SYNLAB INTERNATIONAL GMBH
20.31.1 COMPANY SNAPSHOT
20.31.2 PRODUCT PORTFOLIO
20.31.3 RECENT DEVELOPMENT
20.32 TELOMERE DIAGNOSTICS
20.32.1 COMPANY SNAPSHOT
20.32.2 SERVICE PORTFOLIO
20.32.3 RECENT DEVELOPMENT
20.33 TRINITY BIOTECH
20.33.1 COMPANY SNAPSHOT
20.33.2 REVENUE ANALYSIS
20.33.3 PRODUCT PORTFOLIO
20.33.4 RECENT DEVELOPMENT
20.34 UNILABS
20.34.1 COMPANY SNAPSHOT
20.34.2 PRODUCT PORTFOLIO
20.34.3 RECENT DEVELOPMENT
21 QUESTIONNAIRE
22 RELATED REPORTS
Lista de Tabela
TABLE 1 NUMBER OF PEOPLE WITH DIABETES AMONG 20–79 YEARS OLD (IN MILLION)
TABLE 2 NEW CANCER CASES FOR AGE 85+ IN U.S.
TABLE 3 ACCORDING TO THE UNITED NATIONS, IN 2019, THE TOTAL POPULATION OF AGED PEOPLE ABOVE 65 WAS 703 MILLION AND IS EXPECTED TO REACH 1.5 BILLION BY 2050.
TABLE 4 PER CAPITA AMOUNTS: THE UNITED STATES (1960–2017)
TABLE 5 ASIA PACIFIC HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 6 ASIA PACIFIC CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 ASIA PACIFIC CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 8 ASIA PACIFIC DIABETES TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 ASIA PACIFIC DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 10 ASIA PACIFIC CANCER SCREENING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 ASIA PACIFIC CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 12 ASIA PACIFIC GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 ASIA PACIFIC GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 14 ASIA PACIFIC REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 15 ASIA PACIFIC STD’S IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 ASIA PACIFIC STD’S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 17 ASIA PACIFIC BLOOD PRESSURE TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 20 ASIA PACIFIC HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 21 ASIA PACIFIC MULTI-TEST PANELS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA PACIFIC SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 ASIA PACIFIC SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 24 ASIA PACIFIC HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 25 ASIA PACIFIC BASIC HEALTH SCREENING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA PACIFIC SENIOR CITIZEN PROFILE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 ASIA PACIFIC WOMEN HEALTH CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 ASIA PACIFIC MEN HEALTH CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA PACIFIC HEART CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 ASIA PACIFIC DIABETES CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 ASIA PACIFIC HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
TABLE 33 ASIA PACIFIC BLOOD IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 ASIA PACIFIC URINE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 ASIA PACIFIC SERUM IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 ASIA PACIFIC SALIVA IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 ASIA PACIFIC HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 39 ASIA PACIFIC IMMUNOASSAYS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 40 ASIA PACIFIC MEDICAL IMAGING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 41 ASIA PACIFIC QPCR IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 ASIA PACIFIC QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 43 ASIA PACIFIC Q-FISH IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 ASIA PACIFIC Q-FISH IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 45 ASIA PACIFIC TRF (TERMINAL RESTRICTION FRAGMENT) IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 46 ASIA PACIFIC STELA (SINGLE TELOMERE LENGTH ANALYSIS) IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 47 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 48 ASIA PACIFIC HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 49 ASIA PACIFIC CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 50 ASIA PACIFIC CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 51 ASIA PACIFIC METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 52 ASIA PACIFIC METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 53 ASIA PACIFIC CANCER IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 54 ASIA PACIFIC INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 55 ASIA PACIFIC INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 56 ASIA PACIFIC MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 57 ASIA PACIFIC MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 58 ASIA PACIFIC NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 59 ASIA PACIFIC NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 60 ASIA PACIFIC IMMUNOLOGY-RELATED CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 61 ASIA PACIFIC HEPATITIS-C COMPLICATIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 62 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 63 ASIA PACIFIC HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 64 ASIA PACIFIC DIRECT TENDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 65 ASIA PACIFIC RETAIL SALES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 66 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 67 ASIA PACIFIC HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 68 ASIA PACIFIC HOSPITAL IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 69 ASIA PACIFIC HOSPITAL IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 70 ASIA PACIFIC HOME IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 71 ASIA PACIFIC DIAGNOSTIC LABORATORIES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 72 ASIA PACIFIC OFFICES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 73 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 74 ASIA-PACIFIC HEALTH SCREENING MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 75 ASIA-PACIFIC HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 76 ASIA-PACIFIC CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 77 ASIA-PACIFIC DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 78 ASIA-PACIFIC CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 79 ASIA-PACIFIC GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 80 ASIA-PACIFIC REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 81 ASIA-PACIFIC STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 82 ASIA-PACIFIC OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 83 ASIA-PACIFIC HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 84 ASIA-PACIFIC HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 85 ASIA-PACIFIC SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 86 ASIA-PACIFIC HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 87 ASIA-PACIFIC HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 88 ASIA-PACIFIC QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 89 ASIA-PACIFIC Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 90 ASIA-PACIFIC HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 91 ASIA-PACIFIC CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 92 ASIA-PACIFIC METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 93 ASIA-PACIFIC INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 94 ASIA-PACIFIC MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 95 ASIA-PACIFIC NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 96 ASIA-PACIFIC HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 97 ASIA-PACIFIC HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 98 ASIA-PACIFIC HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 99 CHINA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 100 CHINA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 101 CHINA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 102 CHINA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 103 CHINA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 104 CHINA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 105 CHINA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 106 CHINA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 107 CHINA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 108 CHINA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 109 CHINA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 110 CHINA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 111 CHINA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 112 CHINA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 113 CHINA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 114 CHINA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 115 CHINA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 116 CHINA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 117 CHINA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 118 CHINA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 119 CHINA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 120 CHINA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 121 CHINA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 122 CHINA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 123 JAPAN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 124 JAPAN CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 125 JAPAN DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 126 JAPAN CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 127 JAPAN GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 128 JAPAN REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 129 JAPAN STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 130 JAPAN OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 131 JAPAN HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 132 JAPAN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 133 JAPAN SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 134 JAPAN HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 135 JAPAN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 136 JAPAN QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 137 JAPAN Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 138 JAPAN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 139 JAPAN CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 140 JAPAN METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 141 JAPAN INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 142 JAPAN MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 143 JAPAN NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 144 JAPAN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 145 JAPAN HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 146 JAPAN HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 147 INDIA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 148 INDIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 149 INDIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 150 INDIA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 151 INDIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 152 INDIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 153 INDIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 154 INDIA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 155 INDIA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 156 INDIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 157 INDIA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 158 INDIA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 159 INDIA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 160 INDIA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 161 INDIA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 162 INDIA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 163 INDIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 164 INDIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 165 INDIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 166 INDIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 167 INDIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 168 INDIA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 169 INDIA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 170 INDIA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 171 SOUTH KOREA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 172 SOUTH KOREA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 173 SOUTH KOREA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 174 SOUTH KOREA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 175 SOUTH KOREA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 176 SOUTH KOREA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 177 SOUTH KOREA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 178 SOUTH KOREA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 179 SOUTH KOREA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 180 SOUTH KOREA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 181 SOUTH KOREA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 182 SOUTH KOREA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 183 SOUTH KOREA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 184 SOUTH KOREA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 185 SOUTH KOREA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 186 SOUTH KOREA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 187 SOUTH KOREA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 188 SOUTH KOREA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 189 SOUTH KOREA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 190 SOUTH KOREA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 191 SOUTH KOREA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 192 SOUTH KOREA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 193 SOUTH KOREA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 194 SOUTH KOREA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 195 AUSTRALIA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 196 AUSTRALIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 197 AUSTRALIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 198 AUSTRALIA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 199 AUSTRALIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 200 AUSTRALIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 201 AUSTRALIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 202 AUSTRALIA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 203 AUSTRALIA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 204 AUSTRALIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 205 AUSTRALIA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 206 AUSTRALIA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 207 AUSTRALIA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 208 AUSTRALIA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 209 AUSTRALIA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 210 AUSTRALIA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 211 AUSTRALIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 212 AUSTRALIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 213 AUSTRALIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 214 AUSTRALIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 215 AUSTRALIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 216 AUSTRALIA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 217 AUSTRALIA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 218 AUSTRALIA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 219 SINGAPORE HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 220 SINGAPORE CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 221 SINGAPORE DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 222 SINGAPORE CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 223 SINGAPORE GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 224 SINGAPORE REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 225 SINGAPORE STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 226 SINGAPORE OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 227 SINGAPORE HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 228 SINGAPORE HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 229 SINGAPORE SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 230 SINGAPORE HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 231 SINGAPORE HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 232 SINGAPORE QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 233 SINGAPORE Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 234 SINGAPORE HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 235 SINGAPORE CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 236 SINGAPORE METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 237 SINGAPORE INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 238 SINGAPORE MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 239 SINGAPORE NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 240 SINGAPORE HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 241 SINGAPORE HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 242 SINGAPORE HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 243 THAILAND HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 244 THAILAND CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 245 THAILAND DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 246 THAILAND CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 247 THAILAND GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 248 THAILAND REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 249 THAILAND STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 250 THAILAND OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 251 THAILAND HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 252 THAILAND HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 253 THAILAND SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 254 THAILAND HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 255 THAILAND HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 256 THAILAND QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 257 THAILAND Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 258 THAILAND HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 259 THAILAND CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 260 THAILAND METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 261 THAILAND INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 262 THAILAND MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 263 THAILAND NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 264 THAILAND HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 265 THAILAND HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 266 THAILAND HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 267 MALAYSIA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 268 MALAYSIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 269 MALAYSIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 270 MALAYSIA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 271 MALAYSIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 272 MALAYSIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 273 MALAYSIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 274 MALAYSIA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 275 MALAYSIA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 276 MALAYSIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 277 MALAYSIA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 278 MALAYSIA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 279 MALAYSIA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 280 MALAYSIA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 281 MALAYSIA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 282 MALAYSIA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 283 MALAYSIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 284 MALAYSIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 285 MALAYSIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 286 MALAYSIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 287 MALAYSIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 288 MALAYSIA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 289 MALAYSIA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 290 MALAYSIA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 291 INDONESIA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 292 INDONESIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 293 INDONESIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 294 INDONESIA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 295 INDONESIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 296 INDONESIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 297 INDONESIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 298 INDONESIA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 299 INDONESIA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 300 INDONESIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 301 INDONESIA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 302 INDONESIA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 303 INDONESIA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 304 INDONESIA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 305 INDONESIA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 306 INDONESIA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 307 INDONESIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 308 INDONESIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 309 INDONESIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 310 INDONESIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 311 INDONESIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 312 INDONESIA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 313 INDONESIA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 314 INDONESIA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 315 PHILIPPINES HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 316 PHILIPPINES CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 317 PHILIPPINES DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 318 PHILIPPINES CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 319 PHILIPPINES GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 320 PHILIPPINES REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 321 PHILIPPINES STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 322 PHILIPPINES OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 323 PHILIPPINES HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 324 PHILIPPINES HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 325 PHILIPPINES SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 326 PHILIPPINES HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 327 PHILIPPINES HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 328 PHILIPPINES QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 329 PHILIPPINES Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 330 PHILIPPINES HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 331 PHILIPPINES CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 332 PHILIPPINES METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 333 PHILIPPINES INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 334 PHILIPPINES MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 335 PHILIPPINES NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 336 PHILIPPINES HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 337 PHILIPPINES HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 338 PHILIPPINES HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 339 REST OF ASIA-PACIFIC HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
Lista de Figura
FIGURE 1 ASIA PACIFIC HEALTH SCREENING MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC HEALTH SCREENING MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC HEALTH SCREENING MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC HEALTH SCREENING MARKET : ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC HEALTH SCREENING MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC HEALTH SCREENING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC HEALTH SCREENING MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA PACIFIC HEALTH SCREENING MARKET: MARKET DISTRIBUTION CHANNEL COVERAGE GRID
FIGURE 9 ASIA PACIFIC HEALTH SCREENING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC HEALTH SCREENING MARKET: SEGMENTATION
FIGURE 11 HIGH PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE ASIA PACIFIC HEALTH SCREENING MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 CHOLESTROL TESTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC HEALTH SCREENING MARKET IN 2021 & 2028
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE ASIA PACIFIC HEALTH SCREENING MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA PACIFIC HEALTH SCREENING MARKET
FIGURE 15 PREVALENCE OF CHRONIC DISEASES
FIGURE 16 AGING POPULATION IN THE WORLD (IN MILLION)
FIGURE 17 NORTH AMERICA AGING POPULATION (IN MILLION)
FIGURE 18 EUROPE AGING POPULATION (IN MILLION)
FIGURE 19 ASIA-PACIFIC AGING POPULATION (IN MILLION)
FIGURE 20 ASIA PACIFIC HEALTH SCREENING MARKET: BY TEST TYPE, 2020
FIGURE 21 ASIA PACIFIC HEALTH SCREENING MARKET: BY TEST TYPE, 2021-2028 (USD MILLION)
FIGURE 22 ASIA PACIFIC HEALTH SCREENING MARKET: BY TEST TYPE, CAGR (2021-2028)
FIGURE 23 ASIA PACIFIC HEALTH SCREENING MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 24 ASIA PACIFIC HEALTH SCREENING MARKET: BY PANEL TYPE, 2020
FIGURE 25 ASIA PACIFIC HEALTH SCREENING MARKET: BY PANEL TYPE, 2021-2028 (USD MILLION)
FIGURE 26 ASIA PACIFIC HEALTH SCREENING MARKET: BY PANEL TYPE, CAGR (2021-2028)
FIGURE 27 ASIA PACIFIC HEALTH SCREENING MARKET: BY PANEL TYPE, LIFELINE CURVE
FIGURE 28 ASIA PACIFIC HEALTH SCREENING MARKET: BY PACKAGE TYPE, 2020
FIGURE 29 ASIA PACIFIC HEALTH SCREENING MARKET: BY PACKAGE TYPE, 2021-2028 (USD MILLION)
FIGURE 30 ASIA PACIFIC HEALTH SCREENING MARKET: BY PACKAGE TYPE, CAGR (2021-2028)
FIGURE 31 ASIA PACIFIC HEALTH SCREENING MARKET: BY PACKAGE TYPE, LIFELINE CURVE
FIGURE 32 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE TYPE, 2020
FIGURE 33 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE TYPE, 2021-2028 (USD MILLION)
FIGURE 34 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE TYPE, CAGR (2021-2028)
FIGURE 35 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE TYPE, LIFELINE CURVE
FIGURE 36 ASIA PACIFIC HEALTH SCREENING MARKET: BY TECHNOLOGY, 2020
FIGURE 37 ASIA PACIFIC HEALTH SCREENING MARKET: BY TECHNOLOGY, 2021-2028 (USD MILLION)
FIGURE 38 ASIA PACIFIC HEALTH SCREENING MARKET: BY TECHNOLOGY, CAGR (2021-2028)
FIGURE 39 ASIA PACIFIC HEALTH SCREENING MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 40 ASIA PACIFIC HEALTH SCREENING MARKET: BY CONDITION, 2020
FIGURE 41 ASIA PACIFIC HEALTH SCREENING MARKET: BY CONDITION, 2021-2028 (USD MILLION)
FIGURE 42 ASIA PACIFIC HEALTH SCREENING MARKET: BY CONDITION, CAGR (2021-2028)
FIGURE 43 ASIA PACIFIC HEALTH SCREENING MARKET: BY CONDITION, LIFELINE CURVE
FIGURE 44 ASIA PACIFIC HEALTH SCREENING MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 45 ASIA PACIFIC HEALTH SCREENING MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 46 ASIA PACIFIC HEALTH SCREENING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 47 ASIA PACIFIC HEALTH SCREENING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 48 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE COLLECTION SITES, 2020
FIGURE 49 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE COLLECTION SITES, 2021-2028 (USD MILLION)
FIGURE 50 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE COLLECTION SITES, CAGR (2021-2028)
FIGURE 51 ASIA PACIFIC HEALTH SCREENING MARKET: BY SAMPLE COLLECTION SITES, LIFELINE CURVE
FIGURE 52 ASIA-PACIFIC HEALTH SCREENING MARKET: SNAPSHOT (2020)
FIGURE 53 ASIA-PACIFIC HEALTH SCREENING MARKET: BY COUNTRY (2020)
FIGURE 54 ASIA-PACIFIC HEALTH SCREENING MARKET: BY COUNTRY (2021 & 2028)
FIGURE 55 ASIA-PACIFIC HEALTH SCREENING MARKET: BY COUNTRY (2020 & 2028)
FIGURE 56 ASIA-PACIFIC HEALTH SCREENING MARKET: BY TEST TYPE (2021-2028)
FIGURE 57 ASIA PACIFIC HEALTH SCREENING MARKET: COMPANY SHARE 2020(%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
